PHILADELPHIA – The presence of a gene can predict when a traumatic brain injury (TBI) will lead to early symptoms of Alzheimer’s disease, according to a new study from neuroscientists at the University of Pennsylvania School of Medicine. Amyloid plaque deposits, known primarily for their role in Alzheimer’s disease, are found in nearly one third of people who die from acute TBI, within just hours of a brain injury and in people of all ages. This build up of Alzheimer’s-like deposits can be predicted by a variation in the gene that codes for the amyloid-busting enzyme, neprilsyin.
A single traumatic brain injury (TBI) has emerged as an important risk factor for the later development of Alzheimer’s disease. While plaques in Alzheimer’s disease develop slowly over time and almost exclusively in the elderly, the same pathology can be found rapidly following TBI.
“These findings may be very important for individuals at high risk of TBI, such as participants in contact sports or military personnel,” said senior author Douglas Smith, MD, director of the Penn Center for Brain Injury and Repair and professor of Neurosurgery at the University of Pennsylvania School of Medicine. “A genetic screening tool may be useful in identifying those at risk of developing Alzheimer’s-like amyloid plaques following a traumatic brain injury.”
The amyoid-degrading protein, neprilysin, has been found in abundance following TBI. Variations in an individual’s ability to produce effective neprilsyin may explain why some people generate plaques while others do not.
Researchers looked at genetic samples from 81 head-injured victims who had died acutely following brain trauma between 4 hours and 25 days following their injuries. As expected, in around a third of cases, amyloid deposits were found throughout the brain, similar to what is seen in early Alzheimer’s patients. Researchers found that variations, known as polymorphisms, in part of the neprilysin gene correlated strongly with the presence of these plaques. The study appeared in the Journal of Neurotrauma.
Future studies may investigate whether these genetically predisposed individuals are the same people who go on to develop Alzheimer’s disease after TBI.
The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 16 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $398 million awarded in the 2012 fiscal year.
The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Penn Medicine also includes additional patient care facilities and services throughout the Philadelphia region.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2012, Penn Medicine provided $827 million to benefit our community.